Alnylam Pharmaceuticals, Inc. (ALNY)
422.50
+16.10
(+3.96%)
USD |
NASDAQ |
Jan 07, 16:00
420.00
-2.50
(-0.59%)
Pre-Market: 08:12
Alnylam Pharmaceuticals Research and Development Expense (% of Annual Revenues)
Research and Development Expense (% of Annual Revenues) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median